Paolo Ghia is Professor of Medical Oncology at the Università Vita-Salute San Raffaele, Italy. He is also Deputy Chairman of the Division of Experimental Oncology, at the affiliated hospital, where he is Director of the Strategic Research Program on CLL, which includes a dedicated unit for phase 1 studies.

Davide Rossi is head of the Experimental Hematology research program at the Institute of Oncology Research, Deputy Head of the Division of Hematology and co-chair of the Clinical Lymphoid Tumors Investigation Program at the Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland.

Francesc Bosch is Professor of Hematology, and Head of the Department of Hematology at the University Hospital Vall d’Hebron, and Head of the Department of Hematology at the IOB Institute of Oncology, in Barcelona, Spain.

Stephan Stilgenbauer is Professor of Medicine and Medical Director of the Comprehensive Cancer Center Ulm (CCCU), Head of the Early Clinical Trials Unit (ECTU), and Head of the Division of CLL Dept. of Internal Medicine III at Ulm University, Germany.

Anna Schuh is Associate Professor and Director of Molecular Diagnostics, and Honorary Consultant Haematologist, in the Department of Oncology at the University of Oxford, UK. She is also Visiting Professor at Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.

Ramón García-Sanz, MD, PhD, is a consultant, physician and chief of unit at the University Hospital of Salamanca, Spain; a researcher in hematology at the Centre for Cancer Research in Salamanca; and associate professor in Hemotology at the Faculty of Medicine at the University of Salamanca. He is also the current president of the Spanish Society of Hematology.

Wojciech Jurczak, MD, PhD, is a consultant and a professor of hematology in the Department of Clinical Oncology at the Maria Skłodowska-Curie National Research Institute of Oncology in Kraków, Poland. He also serves at the Research Medical Center (Pratia MCM) in Kraków.

Meletios Dimopoulos, MD, is a professor at and chairman of the Department of Clinical Therapeutics at the National and Kapodistrian University of Athens School of Medicine, Greece. He was previously dean of the medical school and rector of the university.

Christian Buske, MD, is the medical director of the Comprehensive Cancer Center Ulm and the Institute for Experimental Cancer Research at the University Hospital of Ulm, Germany. He is an attending physician and a professor of medicine in the Department of Internal Medicine III and Hematology/Oncology at the University Hospital of Ulm.

Roger Owen, MD, MRCP, FRCPath, is a consultant in clinical hematology and hematopathology at the St James’s Institute of Oncology, Leeds Teaching Hospitals NHS Trust, UK.

Alessandra Tedeschi, MD, PhD, is a consultant in hematology and the medical director of the Department of Hematology at the Niguarda Cancer Center in Milan, Italy.

Catherine Thieblemont, MD, PhD, is Head of the Hemato‑Oncology Department at Hôpital Saint‑Louis, part of the AP‑HP (Assistance Publique–Hôpitaux de Paris) in Paris, France.